 | Your browser does not display parts of our website correctly. We use the latest technology available to provide you with a high quality experience; please upgrade your browser to its latest version to view the contents properly: |
Privia Health Group, Inc. (PRVA) operates as a national physician-enablement company in the United States. 
The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts.
On May 11th, Privia Health Group (PRVA) reported a 1st Quarter March 2022 loss of $0.09 per share on revenue of $313.8 million. The consensus estimate was a loss of $0.24 per share on revenue of $296.3 million. Revenue grew 46.9% on a year-over-year basis. Since then shares have formed a bullish "cup and handle" and are expected to move higher from this formation.
Entry Point: $35.00
Stop Loss: $33.25
Trading Range: $17.99 - $47.77
Target Price: $38.50
